Daiichi Sankyo claims first okay for oncolytic virus in Japa...

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval in Japan for a therapy for cancer based on a virus that selectively kills malig

Karyopharm drug tested in ‘industry-first’ approach to brain...

AbbVie pulls phase 3 ADC trials in glioblastoma after surviv...

AbbVie is the latest company to have an investigational drug for glioblastoma multiforme (GBM) – an aggressive form of brain cancer – fail at the final hurdle.

CarThera raises €9m to tackle the blood-brain barrier

French company CarThera has raised €9 million in its Series B funding round to help it develop ultrasound-based medical devices to treat brain disorders and overcome the challenges of the b

Kick-starting innovation in Glioblastoma

Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?

Celgene hopes device + drug can tackle aggressive brain tumo...

Novocure's Optune will be tested alongside investigational Celgene drug marizomib.